Deprescribing efforts failing dementia patients, study finds
Researchers led by the Beth Israel Deaconess Medical Center, Boston, have examined how a dementia diagnosis impacts medication use patterns in older adults.
Researchers led by the Beth Israel Deaconess Medical Center, Boston, have examined how a dementia diagnosis impacts medication use patterns in older adults.
A smartphone app could enable greater participation in clinical trials for people with frontotemporal dementia (FTD), a devastating neurological disorder that often manifests in midlife.
Apr 1, 2024
0
36
Findings from a study led by researchers in Sweden have suggested that a commercial blood test could detect Alzheimer's disease as accurately as standard lumbar punctures. The blood test detects "p-tau217," a form of the ...
Jan 23, 2024
0
46
Artificial intelligence can predict which people who attend memory clinics will develop dementia within two years with 92 percent accuracy, a largescale new study has concluded.
Dec 16, 2021
0
96
A new study of over 3000 people led by King's College London in collaboration with Lund University, has shown for the first time that a single biomarker can accurately indicate the presence of underlying neurodegeneration ...
Jun 7, 2021
0
27
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health and the Federal Reserve Board of Governors found that Medicare beneficiaries who go on to be diagnosed with dementia are more likely to ...
Nov 30, 2020
0
80
Biomarkers—measurable physical signs of a condition—could be a useful way of testing for Alzheimer's disease, according to a new review study.
Apr 27, 2020
0
281
The Germans Trias i Pujol Health Sciences Research Institute (IGTP) and the Universitat Autònoma de Barcelona (UAB) have discovered the first genetic biomarker to detect Lewy body dementia (LBD), a disease that can be confused ...
Jul 26, 2013
0
1
Inappropriate diagnosis of community-acquired pneumonia (CAP) in hospitalized adults is common, especially among older adults and those with dementia, according to a study published online March 25 in JAMA Internal Medicine.
Mar 27, 2024
0
0
A recent study from UNSW Sydney's Center for Healthy Brain Aging (CHeBA) suggests that the research pace into understanding biomarkers for the diagnosis of vascular cognitive impairment and dementia needs to be accelerated.
Jan 9, 2024
0
0